Drug Trial Radar · NCT01131182
Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)
Last checked: Nov 20, 2026Latest source record: Sep 21, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,147
Actual
Start
Jun 13, 2010
Primary completion
Nov 4, 2010
Study completion Nov 4, 2010
Sponsor
- Lead sponsor
- Merck Sharp & Dohme LLCMerck & Co. (MRK)
- Sponsor type
- Industry
- First posted
- May 26, 2010
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will examine whether the incidence of hypoglycemia in patients fasting for Ramadan is lower when treated with sitagliptin as compared to sulfonylurea treatment.
Conditions
- Type 2 Diabetes Mellitus (T2DM)
Interventions
Sitagliptin phosphateDrug
Sitagliptin 100 mg tablet administered orally once daily over the Ramadan period.
Comparator: SulfonylureaDrug
Sulfonylurea (glibenclamide, glimepiride, or gliclazide) administered orally daily over the Ramadan period as per physician's prescription
MetforminDrug
Participants could continue pre-study metformin as concomitant therapy during the study.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Participants With at Least One Symptomatic Hypoglycemic EventTime frame: 30 days: first day of Ramadan (August 11) to last day of Ramadan (September 10)
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.